MedAssets, Inc., a financial and performance improvement company,
provides technology-enabled products and services for hospitals, health
systems, and other ancillary healthcare providers in the United States.
It operates in two segments, Spend and Clinical Resource Management
(SCM) and Revenue Cycle Management (RCM). The SCM segment offers a suite
of cost management services, supply chain analytics, and data
capabilities; strategic sourcing and group purchasing services; medical
device and clinical resource consulting services; supply chain
outsourcing and procurement services; capital equipment services,
including equipment planning, assessment, and deployment services. The
RCM segment provides a suite of software-as-a-service or Web-based
software and technology-enabled services addressing various revenue
cycle processes, such as patient access and financial responsibility,
clinical documentation, charge capture and revenue integrity, pricing
analysis, claims processing, denials management and reimbursement
integrity, payer contract management, extended business office revenue
recovery, accounts receivable services, and outsourcing services.
Please take a look at the 1-year chart of MDAS (Med Assets, Inc.) below with my added notations:
MDAS has had a rough go of it over the last month and a half, to say
the least. In a market that’s mostly been going higher, MDAS has
continued to break lower. A level that seems to stand out on the stock
is $20. You can see how $20 has been both support (August and November)
and resistance (January, February and April) throughout the year.
Earlier this week the stock fell back below $20.
The Tale of the Tape: MDAS has broken $20 and should
be moving overall lower. Traders could enter a short trade at $20,
while a long trade could be made on a break back above that level with a
stop placed below it.
Please share this article
No comments:
Post a Comment